News

Zymes is engaged in developing a novel, water-soluble, readily applicable patented formulation of nano-micellar complex of CoQ10 and pro-drug form of vitamin E (WS-CoQ10), licensed from the National

NICE’s evaluation took into account peer-reviewed clinical studies that demonstrated VIDAZA as an innovative epigenetic, life-extending, cost-effective therapy for the National Health Service (NHS). Celgene Corporation CEO Robert

The Phase 3 trial will be a 450 patient, randomized, open-label, multi-center trial comparing two treatment regimens for patients with metastatic and/or advanced unresectable soft tissue sarcoma who

The Class I recall, which is not related to Medtronic external insulin pumps for diabetes, is a situation where there is a probability of occurrence of serious adverse

The move came after Janssen found cracks in some of the pre-filled 234-milligram-strength injections which could affect the drug’s sterility, Bloomberg.com reported. The label on the syringe entirely

CMX001 is a potential dual-use therapeutic with evidence of antiviral activity against all five families of double-stranded DNA (dsDNA) viruses that cause morbidity and mortality in humans, including

Under the settlement agreement, PDL paid MedImmune $65m on 15 February 2011 and will pay $27.5m by 10 February 2012 for a total of $92.5m. MedImmune has not

Tivozanib is designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers. Under the terms of

The companies will also introduce Computer-Assisted Physician Documentation (CAPD) technology to provide breakthrough advancements in clinical document improvement (CDI). The idea is to establish CAPD use as a